Swiss National Bank’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $268M | Buy |
3,725,460
+249,800
| +7% | +$19.2M | 0.15% | 109 |
|
|
2025
Q4 | $276M | Sell |
3,475,660
-170,900
| -5% | -$13.5M | 0.16% | 97 |
|
|
2025
Q3 | $275M | Sell |
3,646,560
-174,800
| -5% | -$12M | 0.16% | 104 |
|
|
2025
Q2 | $264M | Buy |
3,821,360
+272,100
| +8% | +$17.8M | 0.16% | 111 |
|
|
2025
Q1 | $240M | Sell |
3,549,260
-4,500
| -0.1% | -$269K | 0.17% | 102 |
|
|
2024
Q4 | $160M | Sell |
3,553,760
-171,000
| -5% | -$9.59M | 0.11% | 155 |
|
|
2024
Q3 | $234M | Sell |
3,724,760
-1,200
| -0% | -$70K | 0.15% | 113 |
|
|
2024
Q2 | $220M | Sell |
3,725,960
-127,900
| -3% | -$8M | 0.15% | 113 |
|
|
2024
Q1 | $307M | Sell |
3,853,860
-162,500
| -4% | -$12.4M | 0.22% | 84 |
|
|
2023
Q4 | $317M | Sell |
4,016,360
-107,400
| -3% | -$7.64M | 0.23% | 77 |
|
|
2023
Q3 | $288M | Sell |
4,123,760
-498,500
| -11% | -$35.3M | 0.23% | 79 |
|
|
2023
Q2 | $320M | Sell |
4,622,260
-592,400
| -11% | -$42.2M | 0.22% | 81 |
|
|
2023
Q1 | $388M | Sell |
5,214,660
-121,000
| -2% | -$10.1M | 0.27% | 70 |
|
|
2022
Q4 | $497M | Sell |
5,335,660
-347,350
| -6% | -$33.5M | 0.36% | 58 |
|
|
2022
Q3 | $542M | Sell |
5,683,010
-10,500
| -0.2% | -$1.04M | 0.39% | 44 |
|
|
2022
Q2 | $528M | Sell |
5,693,510
-24,100
| -0.4% | -$2.35M | 0.36% | 52 |
|
|
2022
Q1 | $579M | Buy |
5,717,610
+701,900
| +14% | +$73.7M | 0.33% | 56 |
|
|
2021
Q4 | $517M | Sell |
5,015,710
-190,000
| -4% | -$17.6M | 0.31% | 59 |
|
|
2021
Q3 | $442M | Sell |
5,205,710
-141,500
| -3% | -$11.9M | 0.28% | 69 |
|
|
2021
Q2 | $446M | Buy |
5,347,210
+313,509
| +6% | +$25.7M | 0.28% | 68 |
|
|
2021
Q1 | $379M | Buy |
5,033,701
+92,000
| +2% | +$6.7M | 0.25% | 72 |
|
|
2020
Q4 | $338M | Sell |
4,941,701
-146,100
| -3% | -$9.5M | 0.24% | 77 |
|
|
2020
Q3 | $297M | Sell |
5,087,801
-70,100
| -1% | -$4.36M | 0.23% | 85 |
|
|
2020
Q2 | $335M | Buy |
5,157,901
+109,000
| +2% | +$6.86M | 0.28% | 67 |
|
|
2020
Q1 | $300M | Buy |
5,048,901
+948,000
| +23% | +$63.3M | 0.32% | 63 |
|
|
2019
Q4 | $305M | Sell |
4,100,901
-189,200
| -4% | -$13.3M | 0.31% | 62 |
|
|
2019
Q3 | $271M | Buy |
4,290,101
+16,598
| +0.4% | +$984K | 0.29% | 71 |
|
|
2019
Q2 | $233M | Sell |
4,273,503
-265,600
| -6% | -$14.3M | 0.25% | 82 |
|
|
2019
Q1 | $245M | Buy |
4,539,103
+97,600
| +2% | +$6.02M | 0.27% | 76 |
|
|
2018
Q4 | $291M | Buy |
4,441,503
+1,145,393
| +35% | +$85.5M | 0.37% | 55 |
|
|
2018
Q3 | $259M | Sell |
3,296,110
-109,900
| -3% | -$7.86M | 0.29% | 70 |
|
|
2018
Q2 | $219M | Buy |
3,406,010
+106,500
| +3% | +$7.02M | 0.25% | 79 |
|
|
2018
Q1 | $205M | Sell |
3,299,510
-501,800
| -13% | -$36M | 0.25% | 80 |
|
|
2017
Q4 | $276M | Sell |
3,801,310
-10,300
| -0.3% | -$749K | 0.3% | 67 |
|
|
2017
Q3 | $310M | Buy |
3,811,610
+12,400
| +0.3% | +$981K | 0.35% | 57 |
|
|
2017
Q2 | $306M | Sell |
3,799,210
-27,200
| -0.7% | -$2.15M | 0.36% | 51 |
|
|
2017
Q1 | $300M | Buy |
3,826,410
+811,100
| +27% | +$64.8M | 0.37% | 50 |
|
|
2016
Q4 | $238M | Sell |
3,015,310
-61,600
| -2% | -$4.98M | 0.38% | 49 |
|
|
2016
Q3 | $274M | Sell |
3,076,910
-97,400
| -3% | -$9.19M | 0.44% | 40 |
|
|
2016
Q2 | $304M | Buy |
3,174,310
+201,700
| +7% | +$20.1M | 0.49% | 36 |
|
|
2016
Q1 | $296M | Buy |
2,972,610
+848,500
| +40% | +$82.5M | 0.54% | 32 |
|
|
2015
Q4 | $208M | Buy |
2,124,110
+12,400
| +0.6% | +$1.21M | 0.5% | 34 |
|
|
2015
Q3 | $204M | Buy |
2,111,710
+198,300
| +10% | +$20.8M | 0.52% | 32 |
|
|
2015
Q2 | $201M | Buy |
1,913,410
+63,400
| +3% | +$6.48M | 0.52% | 31 |
|
|
2015
Q1 | $191M | Buy |
1,850,010
+658,200
| +55% | +$66.6M | 0.51% | 32 |
|
|
2014
Q4 | $115M | Sell |
1,191,810
-50,500
| -4% | -$4.45M | 0.43% | 46 |
|
|
2014
Q3 | $98.9M | Sell |
1,242,310
-31,000
| -2% | -$2.44M | 0.38% | 55 |
|
|
2014
Q2 | $96M | Buy |
1,273,310
+119,600
| +10% | +$9.04M | 0.35% | 59 |
|
|
2014
Q1 | $86.4M | Sell |
1,153,710
-155,300
| -12% | -$11M | 0.34% | 62 |
|
|
2013
Q4 | $93.7M | Sell |
1,309,010
-34,600
| -3% | -$2.22M | 0.37% | 58 |
|
|
2013
Q3 | $76.3M | Buy |
1,343,610
+33,400
| +3% | +$1.99M | 0.32% | 68 |
|
|
2013
Q2 | $74.9M | Buy |
+1,310,210
| New | +$75.9M | 0.33% | 66 |
|
Other funds holding CVS
VCM
VPM
Swiss National Bank's CVS Position: Q1 2026 in Review
Swiss National Bank increased its CVS Health (CVS) stake by 7.2% in Q1 2026, buying an estimated $19.2M and bringing the position to 3,725,460 shares worth $268M. The position accounts for 0.15% of the portfolio, ranked #109.
Swiss National Bank first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $579M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Swiss National Bank held 3,725,460 shares of CVS Health worth $268M as of Q1 2026.
- Swiss National Bank bought 249,800 CVS Health shares in Q1 2026, an estimated $19.2M.
- CVS Health made up 0.15% of Swiss National Bank's portfolio in Q1 2026, its #109 holding.
- Swiss National Bank first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Swiss National Bank's CVS Health position peaked at $579M in Q1 2022.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.